Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Off-Label
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Perspective (2018-2033)
2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Growth Trends by Region
2.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Region (2018-2023)
2.2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Region (2024-2033)
2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Dynamics
2.3.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Industry Trends
2.3.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers
2.3.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges
2.3.4 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue
3.1.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue (2018-2023)
3.1.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue
3.4 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio
3.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2022
3.5 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players Head office and Area Served
3.6 Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Product Solution and Service
3.7 Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Type
4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2024-2033)
5 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Application
5.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2018-2033)
6.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023)
6.4 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2018-2033)
7.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023)
7.4 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2018-2033)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2018-2033)
9.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023)
9.4 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2018-2033)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan Plc (Tobira)
11.1.1 Allergan Plc (Tobira) Company Detail
11.1.2 Allergan Plc (Tobira) Business Overview
11.1.3 Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.1.4 Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.1.5 Allergan Plc (Tobira) Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.2.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Galmed Pharmaceuticals
11.3.1 Galmed Pharmaceuticals Company Detail
11.3.2 Galmed Pharmaceuticals Business Overview
11.3.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.3.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.3.5 Galmed Pharmaceuticals Recent Development
11.4 Genfit SA
11.4.1 Genfit SA Company Detail
11.4.2 Genfit SA Business Overview
11.4.3 Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.4.4 Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.4.5 Genfit SA Recent Development
11.5 Gilead Sciences, Inc.
11.5.1 Gilead Sciences, Inc. Company Detail
11.5.2 Gilead Sciences, Inc. Business Overview
11.5.3 Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.5.4 Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.5.5 Gilead Sciences, Inc. Recent Development
11.6 Intercept Pharmaceuticals, Inc.
11.6.1 Intercept Pharmaceuticals, Inc. Company Detail
11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
11.6.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.6.4 Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.6.5 Intercept Pharmaceuticals, Inc. Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Detail
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.7.4 Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
11.7.5 Zydus Cadila Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Off-Label
Table 3. Key Players of Therapeutic
Table 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2018-2023)
Table 8. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2024-2033)
Table 10. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Trends
Table 11. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers
Table 12. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges
Table 13. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints
Table 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players (2018-2023)
Table 16. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2022)
Table 17. Ranking of Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Product Solution and Service
Table 21. Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Allergan Plc (Tobira) Company Detail
Table 47. Allergan Plc (Tobira) Business Overview
Table 48. Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 49. Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 50. Allergan Plc (Tobira) Recent Development
Table 51. Bristol Myers Squibb Company Detail
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 54. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Galmed Pharmaceuticals Company Detail
Table 57. Galmed Pharmaceuticals Business Overview
Table 58. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 59. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 60. Galmed Pharmaceuticals Recent Development
Table 61. Genfit SA Company Detail
Table 62. Genfit SA Business Overview
Table 63. Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 64. Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 65. Genfit SA Recent Development
Table 66. Gilead Sciences, Inc. Company Detail
Table 67. Gilead Sciences, Inc. Business Overview
Table 68. Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 69. Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 70. Gilead Sciences, Inc. Recent Development
Table 71. Intercept Pharmaceuticals, Inc. Company Detail
Table 72. Intercept Pharmaceuticals, Inc. Business Overview
Table 73. Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 74. Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 75. Intercept Pharmaceuticals, Inc. Recent Development
Table 76. Zydus Cadila Company Detail
Table 77. Zydus Cadila Business Overview
Table 78. Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 79. Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023) & (US$ Million)
Table 80. Zydus Cadila Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type: 2022 VS 2033
Figure 3. Off-Label Features
Figure 4. Therapeutic Features
Figure 5. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Provider Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Non-Alcoholic Steatohepatitis (NASH) Treatment Report Years Considered
Figure 11. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players in 2022
Figure 15. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2022
Figure 17. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2018-2033)
Figure 19. United States Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2018-2033)
Figure 23. Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2018-2033)
Figure 31. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Allergan Plc (Tobira) Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 46. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 47. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 48. Genfit SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 49. Gilead Sciences, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 50. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 51. Zydus Cadila Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed